摘要 |
PROBLEM TO BE SOLVED: To provide a TNF-αproduction inhibitor useful as a therapeutic agent for autoimmune diseases such as rheumatoid arthritis. SOLUTION: The novel compound having a structure represented by general formula [1] [wherein A is -(NR<SP>4</SP>)-, -(CR<SP>5</SP>R<SP>6</SP>)- or -O-; B is an alkylene or alkenylene group; R<SP>1</SP>, R<SP>2</SP>, R<SP>4</SP>, R<SP>5</SP>and R<SP>6</SP>are each a hydrogen atom, an alkyl group, an alkenyl group, an adamantylalkyl group or the like; R<SP>3</SP>is an aryl group or an unsaturated heterocyclic group; and X is an oxygen or sulfur atom] and salts thereof have excellent TNF-αproduction inhibitory activities. COPYRIGHT: (C)2006,JPO&NCIPI |